Dent Joins Duke IBC Consortium as Clinical Director

Susan Dent, MD, FRCPC, associate director, Clinical Research, Duke Cancer Institute Breast Cancer Disease Group, and co-director of the Duke Cardio-Oncology Program, has joined the Duke Consortium for Inflammatory Breast Cancer as clinical director. Gayathri Devi, PhD, is the consortium's program director. 

Dent joined Duke as a professor in the Dept. of Medicine, Division of Medical Oncology, in Sept. 2018.
 
An expert in breast cancer treatment-related toxicities and cardiovascular health in cancer patients, she's the Duke lead for the Translational Breast Cancer Research Consortium and current president of the International Cardio-Oncology Society Board of Directors.
 

Related News

Team DCI representing at Komen Triangle Race for the Cure
UPDATE: DCI Teams Raised More than $12K in Race for the Cure
Read More
DCI Komen Navigating Survivorship ad
WATCH NOW: "Navigating Breast Cancer Survivorship"
Read More
IBC Consortium Translates Research Into Action
Read More
Dent Named Associate Director For Clinical Research, Breast Oncology
Read More
Topics
breast cancer, breast cancer research, Inflammatory Breast Cancer, Susan Dent

Learn More

For more information on breast cancer care at Duke Health, visit Breast Cancer Treatment Options: Expert Guidance for Your Breast Cancer Care. To find a doctor, visit Find A Specialist

For more information on inflammatory breast cancer research at DCI, contact Sarah Weaver, MPH, Research Program Manager, Duke Consortium for Inflammatory Breast Cancer.